Tg Therapeutics (TGTX) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Tg Therapeutics (TGTX) over the last 7 years, with Q3 2025 value amounting to -$6.5 million.
- Tg Therapeutics' Other Gross PP&E Adjustments rose 1227.9% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.5 million, marking a year-over-year increase of 1227.9%. This contributed to the annual value of -$7.2 million for FY2024, which is 1116.77% up from last year.
- Per Tg Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$6.5 million for Q3 2025, which was up 1227.9% from -$6.7 million recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Other Gross PP&E Adjustments peaked at -$6.5 million during Q3 2025, and registered a low of -$9.1 million during Q1 2021.
- Over the past 5 years, Tg Therapeutics' median Other Gross PP&E Adjustments value was -$8.5 million (recorded in 2023), while the average stood at -$8.2 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 336.21% in 2022, then surged by 1238.3% in 2025.
- Tg Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$8.6 million in 2021, then decreased by 3.0% to -$8.9 million in 2022, then rose by 9.43% to -$8.0 million in 2023, then increased by 11.17% to -$7.2 million in 2024, then rose by 9.09% to -$6.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$6.5 million in Q3 2025, compared to -$6.7 million in Q2 2025 and -$6.9 million in Q1 2025.